viral vectors market

Viral Vectors Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Published Date: 2021-01-27
  • Report ID: 47363
  • Pages: 132
  • Format: prudent report format

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Viral Vectors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Viral Vectors market segmented into
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others

Based on the end-use, the global Viral Vectors market classified into
Cancers
Inherited Disorders
Viral Infections
Others

Based on geography, the global Viral Vectors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory


Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL VIRAL VECTORS INDUSTRY
2.1 Summary about Viral Vectors Industry
2.2 Viral Vectors Market Trends
2.2.1 Viral Vectors Production & Consumption Trends
2.2.2 Viral Vectors Demand Structure Trends
2.3 Viral Vectors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Retroviral Vectors
4.2.2 Lentiviral Vectors
4.2.3 Adenoviral Vectors
4.2.4 Herpes Simplex Virus Vectors
4.2.5 Chimeric Viral Vectors
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cancers
4.3.2 Inherited Disorders
4.3.3 Viral Infections
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Retroviral Vectors
5.2.2 Lentiviral Vectors
5.2.3 Adenoviral Vectors
5.2.4 Herpes Simplex Virus Vectors
5.2.5 Chimeric Viral Vectors
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cancers
5.3.2 Inherited Disorders
5.3.3 Viral Infections
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Retroviral Vectors
6.2.2 Lentiviral Vectors
6.2.3 Adenoviral Vectors
6.2.4 Herpes Simplex Virus Vectors
6.2.5 Chimeric Viral Vectors
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cancers
6.3.2 Inherited Disorders
6.3.3 Viral Infections
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Retroviral Vectors
7.2.2 Lentiviral Vectors
7.2.3 Adenoviral Vectors
7.2.4 Herpes Simplex Virus Vectors
7.2.5 Chimeric Viral Vectors
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cancers
7.3.2 Inherited Disorders
7.3.3 Viral Infections
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Retroviral Vectors
8.2.2 Lentiviral Vectors
8.2.3 Adenoviral Vectors
8.2.4 Herpes Simplex Virus Vectors
8.2.5 Chimeric Viral Vectors
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cancers
8.3.2 Inherited Disorders
8.3.3 Viral Infections
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Retroviral Vectors
9.2.2 Lentiviral Vectors
9.2.3 Adenoviral Vectors
9.2.4 Herpes Simplex Virus Vectors
9.2.5 Chimeric Viral Vectors
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cancers
9.3.2 Inherited Disorders
9.3.3 Viral Infections
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 BioReliance
10.1.2 Cobra Biologics
10.1.3 Oxford BioMedica
10.1.4 UniQure
10.1.5 FinVector
10.1.6 MolMed
10.1.7 MassBiologics
10.1.8 Richter-Helm
10.1.9 FUJIFILM Diosynth Biotechnologies
10.1.10 Lonza
10.1.11 Aldevron
10.1.12 Eurogentec
10.1.13 Cell and Gene Therapy Catapult
10.1.14 Biovian
10.1.15 Brammer Bio
10.1.16 VGXI
10.1.17 PlasmidFactory
10.2 Viral Vectors Sales Date of Major Players (2017-2020e)
10.2.1 BioReliance
10.2.2 Cobra Biologics
10.2.3 Oxford BioMedica
10.2.4 UniQure
10.2.5 FinVector
10.2.6 MolMed
10.2.7 MassBiologics
10.2.8 Richter-Helm
10.2.9 FUJIFILM Diosynth Biotechnologies
10.2.10 Lonza
10.2.11 Aldevron
10.2.12 Eurogentec
10.2.13 Cell and Gene Therapy Catapult
10.2.14 Biovian
10.2.15 Brammer Bio
10.2.16 VGXI
10.2.17 PlasmidFactory
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.